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Summary 
Rats given high doses of colchicine (300-400 ug, i.c.v.) 
were used to investigate the comparative distribution of 
Leu-enkephalin and bovine adrenal medullary enkephalin- 
precursor fragment (BAM-22P) in the brain. Leu-enkephalin 
immunoreactive neurons have a widespread distribution 
throughout the neuraxis. In most areas adjacent section 
analysis showed BAM-22P and Leu-enkephalin immunoreactive 
perikarya to be similarly localized. Brain enkephalin 
biosynthetic mechanisms might therefore be similar to those 
regulating adrenal medullary enkephalin biosynthesis. 
The enkephalins (I) have been shown to occur in neuronal systems in many 
brain sites. The highest radioimmunoassayable levels occur in striatum, with 
lower amounts found in diencephalon, brainstem, and cerebral cortex (2). 
With the use of immunohistochemical techniques, many investigators have been 
able to show widespread immunoreactivity in brain and spinal cord (3-10). In 
many regions, such as cerebral cortex and several limbic areas, enkephalins 
occur in very low concentrations, and are thus not easily detectable by 
immunocytochemistry. To overcome this problem we have used high doses of 
colchicine administered i.c.v, to enhance cell body visualization and have 
been able to detect widespread enkephalin immunoreactivity in several 
cortical-limbic structures (Khachaturian et al., submitted). 
The enkephalins also occur outside of the brain. In particular, the 
adrenal medullary cells synthesize enkephalins via a precursor containing 6 
copies of Met-enkephalin and I copy of Leu-enkephalin (11-13). In the 
present study, we have used antisera to both Leu-enkephalin and an enkephalin 
precursor fragment from bovine adrenal medulla (BAM-22P; 14) to demonstrate a 
close anatomical correlation between the two immunoreactivities in the rat 
central nervous system. 
MATERIALS AND METHODS 
Adult male Sprague-Dawley rats were injected i.c.v, with high doses of 
colchicine (300-400 ug in 10 ul 0.9% saline). After 24-48 hours, the animals 
were anesthetized with sodium pentobarbital and then perfused through the 
aorta with iee-co!d 4% neutral-buffered formaldehyde for 30 minutes. The 
brains were removed promptly and refrigerated overnight in 15% sucrose. The 
• O . 
tissues were frozen ~n -40 C Isopentane and processed for PAP immunocyto- 
chemistry (15) using antisera generated against Leu-enkephalin and the non- 
enkephalin portion of BAM-22P. The tissues were incubated with primary 
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rabbit antiserum to each peptide for I hour at 37°C and overnight at 4°C. 
These were then washed in phosphate-buffered saline (PBS), incubated with 
goat-anti-rabbit serum (Sternberger-Meyer) for 30 minutes at 37°C and over- 
night at 4°C. The tissues were again washed in PBS, incubated with horse- 
radish peroxidase (HRP) antiserum for 40 minutes, and subsequently with HRP 
enzyme (Sigma, Type VI) for 30 minutes. The tissues were then washed in PBS 
and immersed in a solution of diaminobenzidine (Sigma) and 0.03% hydrogen 
peroxide for 15 minutes. They were then washed in distilled water, osmicated 
(2%), washed, and dehydrated. 
RESULTS 
Leu-enkephalin immunoreactivity was observed to be widely distributed 
throughout the neuraxis (Table I). Most of these areas also contained 
BAM-22P immunoreactivity (Table I). Serial section analysis with antisera 
against Leu-enkephalin and BAM-22P showed these two immunoreactivities to be 
distributed similarly (Figure I). Leu-enkephalin immunoreactivity occurred 
FIG. I 
Comparative immunocytochemistry of Leu-enkephalin (A,C) and BAM-22P (B,D) 
in adjacent tissue sections through the anterior olfactory nucleus (A,B) 
and caudate-putamen (CPU)/globus pallidus (GP) (C,D). Note the similar 
anatomical distribution of perikarya, fibers, and terminals in each 
respective region. Bar = 100 um. 
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TABLE I 
Comparative distribution of Leu-enkephalin (ENK) and BAM-22P (BAM) 
immunoreactivities in selected rat brain sites 
Region 
Perikarya Fibers/Terminals 
ENK BAM ENK BAM 
Olfactory bulb + + 
Anterior Olfactory n. + + + + 
Neocortex + + 
Paleocortex: cingulate + + 
piriform + + + + 
entorhinal + + + + 
Amygdala + + + 
Hippocampal formation: perforant path + + 
dentate gyrus + + 
hippocampus + + + 
N. accumbens + + + + 
Caudate-putamen + + + + 
Globus pallidus + + 
Septum + + + + 
Hypothalamus: supraoptic n. + 
paraventricular n. (parvo) + + + + 
ventromedial n. + + + + 
arcuate n. + + + + 
lateral hypothalamic area + + + + 
mammillary bodies + + + + 
Thalamus: anterior n. + + 
periventricular n. + + + + 
Habenula + + 
Interpeduncular n. + + + 
Substantia nigra + + 
Inferior colliculus + + + + 
Periaqueductal gray + + + + 
N. raphe dorsalis + + + + 
N. locus coeruleus + + 
Parabrachial n. + + + + 
Trigeminal sensory nn. + + 
N. raphe magnus + + + + 
N. reticularis paragigantocellularis + + + + 
Vestibular nn. + + + + 
N. tractus solitarius + + + + 
Spinal cord + + + + 
in perikarya0 processes and terminals of neurons, whereas the immunoreactive 
signal of BAM-22P was for the most part confined to neuronal perikarya. 
Furthermore, the immunoreactive signal obtained by the anti- Leu-enkephalin 
serum was completely blocked by the addition of excess Leu-enkephalin but not 
BAM-22P. Likewise, while BAM-22P blocked the immunoreactive signal of 
anti-BAM-22P serum, neither Leu- nor Met-enkephalin demonstrated an effective 
blockade of that signal. 
DISCUSSION 
Colchicine-pretreated rats have been used to investigate the comparative 
distribution of Leu-enkephalin and BAM-2~P in the central nervous system. 
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Careful cross-blocking studies confirmed the specificity of each antiser~ 
for its particular peptide. Treatment with large doses of colchicine allowed 
the visualization of immunoreactivity in neuronal perikarya otherwise unde- 
tectable in rats treated with lower doses or without colchicine (10). Leu- 
enkephalin immunoreactivity was also enhanced in processes and terminals of 
neurons. In contrast, BAM-22P immunoreactivity was mainly confined to peri- 
karya, although faint terminal-like or diffuse immunoreactivity was also 
noted. This observation might be due to the fact that BAM-22P is a part of 
the enkephalin precursor molecule and might, therefore, be more concentrated 
within neuronal perikarya. When compared through serial section analysis, 
Leu-enkephalin and BAM-22P immunoreactive perikarya, fibers and terminals 
appeared to be similarly distributed in many brain sites. This observation 
is suggestive of similarity between the adrenal medullary enkephalin precur- 
sor (11-13) and the enkephalin precursor in brain. We are presently investi- 
gating whether these two immunoreactivities are co-localized within the same 
neurons. The present results indicate that at least some brain enkephalin 
biosynthesis might occur via a precursor similar or identical to the enkeph- 
alin precursor found in the adrenal medulla. 
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